Dados do Trabalho

Título

IMPACTS OF EPILEPSY IN PEDIATRIC PATIENTS IN BRAZIL: AN ANALYSIS OF RISING INCIDENCE, DURING A TWELVE-YEAR EPIDEMIOLOGICAL PANORAMA

Introdução

Epilepsy is a serious and common neurological disease that affects more than 70 million people worldwide. Its distribution pattern is bimodal, with greater impact among infants and older individuals. Due to the remarkably higher probability of being able to control cases of epilepsy in childhood, especially in children up to nine years of age, it is important to analyze its epidemiology, in order to avoid higher rates of lost years of quality of life and therefore better combat its impacts.

Objetivo

To analyze, through hospitalization data, the impact of epilepsy in infants up to nine years of age, using an epidemiological range of 12 years.

Método

This is an observational, descriptive and analytical epidemiological study, where the "TabNet" platform was accessed, and the "epidemiological and morbidities" axis was chosen, selecting the topic "Hospital Morbidity of the SUS (SIH/SUS)". Next, the subtopic "General, by place of hospitalization - from 2008 onwards" was chosen, and "Brazil by Region and Federation Unit" was picked as the area of geographic coverage. Finally, the content "hospitalizations" was selected during the period "2012-2023" and filtered by the morbidity "Epilepsy", thereby obtaining the present data.

Resultados

From 2012 to 2023, 639,983 hospitalizations were recorded, of which 212,713 (33.34%) were cases of patients up to 9 years of age. When analyzing this pediatric group, dividing this time interval into three increasing quadrennium, and calculating their respective mean and standard deviation (±) values associated with hospitalizations, 16,648 (±537), 18,357 (±927), and 18,173 (±1,532) hospitalizations were dated, with consecutive variations of +10.27% and -1.1%. In addition, the peak of occurrences took place in 2022, with 19,974 cases.

Conclusão

Therefore, this study verified that hospitalizations for epilepsy in this population are of notably large incidence. Although, after an initial growth, a relative stabilization was observed in the last four years, a high standard deviation suggests that, as this moment is closely associated with the COVID-19 pandemic, underreporting of hospitalizations may have increased, obscuring a scenario of probable increase of incidence of pediatric epilepsy, confluent with the peak of hospitalizations in 2022. In light of this, more studies that analyze the factors associated with the context of this disease are necessary, in order to possibly reduce its impacts in Brazil.

Referências

LETÍCIA, A. et al. Course and prognosis of adult-onset epilepsy in Brazil: A cohort study. Epilepsy & Behavior, v. 105, p. 106969–106969, 1 abr. 2020.

OSHIRO, C. A.; CASTRO, L. H. M. Cannabidiol and epilepsy in Brazil: a current review. Arquivos de Neuro-Psiquiatria, v. 80, n. 5 suppl 1, p. 182–192, maio 2022.

TabNet Win32 3.0: Morbidade Hospitalar do SUS - por local de internação - Brasil. Disponível em: .

THIJS, R. D. et al. Epilepsy in adults. The Lancet, v. 393, n. 10172, p. 689–701, fev. 2019.

Palavras Chave

Pediatric Epilepsy; Epidemiology Epilepsy; hospitalizations